Clinical trial
Hydroxyurea in Primary Progressive Multiple Sclerosis
NCT01103583 is registered in ClinicalTrials.gov with S. Andrea Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxyurea in Primary Progressive Multiple Sclerosis
- Lead sponsor
- S. Andrea Hospital
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- July 31, 2011
- Completion date
- Not reported
- Enrollment
- 33 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.